AstraZeneca Securities Delisted by NYSE
Ticker: AZN · Form: 25-NSE · Filed: Apr 8, 2026 · CIK: 0000901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 25-NSE |
| Filed Date | Apr 8, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: delisting, exchange-filing, securities
TL;DR
NYSE is delisting AstraZeneca securities on 4/8/26. Check your holdings.
AI Summary
On April 8, 2026, the New York Stock Exchange (NYSE) filed a Form 25-NSE to report the delisting of securities for AstraZeneca PLC. This action is typically taken for securities that have matured, been redeemed, or retired.
Why It Matters
This filing indicates that certain AstraZeneca securities will no longer be listed or traded on the NYSE, potentially impacting investors holding those specific securities.
Risk Assessment
Risk Level: low — This is a standard administrative filing for securities that have reached the end of their lifecycle on the exchange, not indicative of company distress.
Key Players & Entities
- NEW YORK STOCK EXCHANGE LLC (company) — Filer
- ASTRAZENECA PLC (company) — Subject Company
- 2026-04-08 (date) — Filing and Effectiveness Date
FAQ
What is the purpose of a Form 25-NSE filing?
A Form 25-NSE is filed by a national security exchange to report the removal from listing and registration of matured, redeemed, or retired securities.
Who is filing this Form 25-NSE?
The New York Stock Exchange LLC (NYSE) is filing this Form 25-NSE.
Which company's securities are being delisted?
AstraZeneca PLC's securities are being delisted.
When is the effectiveness date for this delisting?
The effectiveness date for this delisting is April 8, 2026.
What is AstraZeneca PLC's SIC code?
AstraZeneca PLC's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 25-NSE (Form 25-NSE) was filed with the SEC on April 8, 2026 regarding ASTRAZENECA PLC (AZN).